Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Pharmaceutical Investing
Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study Pharmaceutical Investing
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain Pharmaceutical Investing
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore Life Science Investing
U.S. FDA Approves VRAYLAR® as an Adjunctive Treatment for Major Depressive Disorder Pharmaceutical Investing
Ambrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price Life Science Investing
AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® for Functional Constipation in Children and Adolescents 6 to 17 Years of Age Pharmaceutical Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
